Calcifying epithelial odontogenic tumor

The calcifying epithelial odontogenic tumor (CEOT) is a rare, benign, locally aggressive epithelial odontogenic neoplasm characterized by the production of amyloid-like material that tends to undergo calcification.[1][2] It is thought to originate from the dental lamina or its remnants.[1] The tumor occurs predominantly as an intraosseous (central) lesion of the jaws, with a strong predilection for the posterior mandible, and is frequently associated with an unerupted tooth.[1][3] The hallmark radiographic pattern is a mixed radiolucent-radiopaque lesion with scattered calcifications that may approach the density of enamel.[4] Management centers on surgical excision with adequate margins; the overall prognosis is favorable, though long-term follow-up is essential given the potential for late recurrence.[1][3]

• Current designation: Calcifying epithelial odontogenic tumor (CEOT), classified under benign epithelial odontogenic tumors in the 5th edition (2022) of the WHO Classification of Head and Neck Tumors.[2][5]
• Eponym: Pindborg tumor, after J.J. Pindborg, who provided the definitive description in 1958; the eponym was introduced by Shafer and colleagues in 1963.[6]
• Historical note: The lesion was first described in English by Thoma and Goldman in 1946, with even earlier German-language documentation by Heinz in 1932.[6]
• Recognized histopathological subtypes (WHO 2022): clear cell variant, cystic/microcystic variant, and non-calcifying/Langerhans cell (LC)-rich variant.[2][5]

• Frequency: Accounts for approximately 1% of all odontogenic tumors, with fewer than 400 cases reported globally through 2017.[3][7]
• Age: Broad range (20–60 years); mean age at diagnosis approximately 40 years. Extremely rare in children and adolescents (~7% of cases).[1][8]
• Sex: Near-equal distribution between males and females.[1][3]
• Anatomic distribution:
  • Mandible predominates (~65–70% of cases), with the premolar-molar region most commonly affected.[1][3][6]
  • Maxilla accounts for approximately 30% of cases.[1]
• Variants:
  • Intraosseous (central): ~94% of cases.[1]
  • Extraosseous (peripheral): ~6%; diagnosed at a slightly younger mean age (~34 years).[1][3]

CEOT typically presents as a slow-growing, painless swelling of the jaw, often discovered incidentally on radiographic examination.[9][10] Symptoms, when present, may include:

• Swelling: Firm, non-tender buccal or lingual expansion of the affected jaw segment.[6]
• Tooth-related findings: An unerupted or impacted tooth is associated with approximately 60% of intraosseous cases. Tooth displacement is occasionally observed; root resorption is uncommon.[1][6]
• Maxillary lesions: May produce non-specific sinus symptoms, nasal obstruction, or infraorbital fullness when extending into the maxillary sinus or nasal cavity.[5][9]
• Signs of local aggressiveness: Bone expansion with or without cortical disruption, tooth displacement, root resorption, and maxillary sinus invasion. Approximately half of central lesions show cortical perforation.[3][6]
• Peripheral CEOT: Presents as a sessile, firm, smooth-surfaced gingival mass, most often in the anterior maxilla; underlying bone erosion occurs in about 40% of peripheral cases.[3][6]
• Tempo: Indolent growth over months to years. Larger lesions are more common in the mandible.[6]

The radiographic appearance of CEOT is variable and depends on the degree of calcification, lesion maturity, and size.[1][6][10]

Location and distribution

• Strong predilection for the posterior mandible (premolar-molar region), often extending to the ramus in large lesions.[1][2][3]
• Maxillary lesions occur in approximately 30% of cases and may extend into the maxillary sinus, nasal cavity, or toward the infraorbital margin.[1][5]
• Multifocal synchronous CEOT is exceedingly rare; a case with 13 independent lesions across all quadrants has been documented.[7]

Relationship to teeth

• Association with an unerupted or impacted tooth in approximately 60% of intraosseous cases, often presenting as a pericoronal radiolucency.[1][6]
• Occasional association with an odontoma.[1]
• Tooth displacement is documented but uncommon; root resorption is rare.[6]

Periphery and shape

• Borders range from well-defined to irregular; well-defined margins are reported in approximately 48% of cases.[6]
• Unilocular configuration in approximately 30–36% of cases; multilocular in the remainder.[6]
• Scalloped or irregular margins may be seen, particularly in larger or more aggressive lesions.

Internal architecture

The internal density pattern is the most diagnostically useful radiographic feature and evolves with lesion maturity:[1][6]

• Radiolucent: Approximately 48–51% of cases appear entirely radiolucent, particularly early or small lesions, mimicking odontogenic cysts or ameloblastoma.[6]
• Mixed radiolucent-radiopaque: Approximately 47–48% show scattered radiopaque foci within a radiolucent background — the classic and most recognizable pattern. The radiopaque component represents calcified amyloid-like material and may be as dense as tooth enamel, a distinguishing feature from most other mineralizing jaw lesions.[4][6]
• Densely radiopaque: Rarely, heavily calcified lesions may mimic an odontoma or ossifying fibroma.[9]
• Maturation pattern: Calcifications increase in size and opacity over time; larger and more mature lesions tend to exhibit a mixed or predominantly radiopaque pattern.[1][6]

Effects on surrounding structures

• Bone expansion: Observed in approximately 32% of cases, typically with buccal and/or lingual cortical thinning.[6][11]
• Cortical perforation: Reported in about half of central lesions.[3]
• Inferior alveolar canal: Large mandibular lesions may displace or involve the canal; volumetric imaging delineates canal involvement more reliably than conventional radiographs.[11]
• Maxillary sinus: Maxillary CEOT may opacify or invade the sinus.[5][6]

Recognized radiographic variants

• Pericoronal type: Radiolucency surrounding the crown of an unerupted tooth, closely resembling a dentigerous cyst.[1][6]
• Non-pericoronal type: Radiolucent or mixed lesion without an associated unerupted tooth, arising in a tooth-bearing or edentulous area.
• Langerhans cell-rich variant: Tends to present as a purely radiolucent, unilocular lesion without calcification, often with cortical perforation and root resorption — a more aggressive radiographic pattern than conventional CEOT.[2]

Volumetric imaging contributions

CBCT and CT provide superior assessment of cortical integrity, internal calcification pattern, three-dimensional extent, and relationship to the inferior alveolar canal and maxillary sinus compared with panoramic radiography.[11][12] These modalities are particularly valuable for surgical planning in large or maxillary lesions.

CT demonstrates an expanding, well-defined lesion with scattered high-density calcifications and cortical thinning or perforation.[11][13] On MRI, CEOT is predominantly hypointense on T1-weighted sequences and of mixed hyperintensity on T2-weighted sequences; the extent of soft-tissue involvement and mandibular canal encasement is well delineated.[11] MRI is most useful when soft-tissue extension beyond bone — particularly in maxillary lesions approaching the orbit, infratemporal fossa, or skull base — must be assessed for surgical planning.[11][14]

The differential diagnosis of CEOT depends heavily on the internal density pattern. Purely radiolucent lesions mimic odontogenic cysts and ameloblastoma, while mixed radiolucent-radiopaque lesions overlap with other calcifying odontogenic neoplasms.[6]

The highest-risk diagnostic pitfall is misinterpreting a non-calcifying CEOT — particularly the Langerhans cell-rich variant — as a simple odontogenic cyst or, on histopathology, as squamous cell carcinoma due to the nuclear pleomorphism of CEOT epithelial cells.[2][4] Incisional biopsy with Congo red staining for amyloid is essential when CEOT is suspected.

Conventional microscopic features

• Epithelial component: Sheets, nests, islands, and cords of polyhedral eosinophilic epithelial cells with prominent intercellular bridges. Nuclear and cellular pleomorphism — including giant nuclei and hyperchromasia — is characteristic and should not be mistaken for malignancy.[1][2][4][6]
• Amyloid-like material: Extracellular, amorphous, eosinophilic, hyaline substance deposited within and around epithelial islands. Stains positively with Congo red and exhibits apple-green birefringence under polarized light. This material is immunoreactive for cytokeratins and is derived from odontogenic ameloblast-associated protein (ODAM).[2][4][17]
• Calcification: Amyloid-like material undergoes progressive calcification, forming concentric laminations known as Liesegang rings. These calcified masses correspond to the radiopaque foci seen on imaging.[2][4]
• Proliferative activity: Low Ki-67 labeling index, consistent with slow growth.[18][19]

WHO-recognized subtypes

• Clear cell variant: Contains glycogen-rich clear cells; reported in approximately 33 of 339 analyzed cases. Despite earlier suggestions of more aggressive behavior, large analyses indicate a recurrence rate (~10.7%) comparable to conventional CEOT.[3][19]
• Cystic/microcystic variant: Features cystic spaces within the tumor architecture.[2][5]
• Langerhans cell (LC)-rich / non-calcifying variant: Characterized by smaller epithelial nests, abundant Langerhans cells (CD1a-positive), prominent inflammatory infiltrate, and absence of calcification. Tends toward more locally aggressive behavior with cortical perforation and root resorption.[2]

Radiologic-pathologic correlation

The degree of calcification on imaging directly reflects the proportion of calcified amyloid in the specimen: early or amyloid-rich/calcification-poor tumors appear radiolucent, while calcification-rich tumors produce the classic mixed or radiopaque pattern.[6][18] The LC-rich variant's purely radiolucent appearance correlates with the histologic absence of calcified amyloid.[2]

Important diagnostic distinction

The amyloid-rich variant of central odontogenic fibroma can closely mimic CEOT histologically. CD1a immunostaining and careful evaluation of the stromal component help differentiate these entities.[20]

Surgical treatment

• Mandibular CEOT: Conservative surgical excision (enucleation with a margin of macroscopically normal bone) is the recommended treatment, given the tumor's relatively indolent behavior. Mutilating procedures such as hemimandibulectomy are generally unwarranted for conventional CEOT.[1][6]
• Maxillary CEOT: More aggressive resection is advised, as maxillary lesions tend to grow more rapidly, are less well-confined by cortical boundaries, and may extend into the sinus, nasal cavity, or orbit.[1][5][6]
• Simple curettage alone is associated with higher recurrence rates and is not recommended as definitive treatment.[3]

Recurrence

• Overall recurrence rate is approximately 10–15%, though estimates vary across series.[3][8]
• Recurrence rates by variant: central CEOT ~11.6%, peripheral CEOT ~18.8%, clear cell variant ~10.7%.[3]
• Malignant transformation is exceedingly rare (8 cases among 339 analyzed), with a recurrence rate of ~43% in those cases. Malignant CEOT has been associated with metastasis to lymph nodes, lungs, and bone.[3][6]
• Late recurrence — even decades after initial surgery — has been documented, underscoring the need for prolonged surveillance.[21]

Follow-up

A minimum of 5 years of clinical and radiographic follow-up is recommended.[1] Given reports of recurrence beyond 20 years, extended or indefinite surveillance is prudent, particularly for maxillary lesions and cases treated conservatively.[1][21]

Prognosis

Overall prognosis is favorable. The tumor behaves less aggressively than ameloblastoma in most cases.[6] Prognostic factors associated with a less favorable outcome include maxillary location, cortical perforation, large size, and malignant transformation.[1][3][6]

Molecular findings

EGFR T790M mutations have been identified in both conventional and Langerhans cell-rich variants of CEOT, suggesting a shared molecular pathogenesis despite divergent clinical and histologic phenotypes.[2] No recurrent driver mutations in the MAPK, WNT, or Hedgehog pathways — commonly implicated in other odontogenic tumors — have been established for CEOT.[22] The molecular pathogenesis remains incompletely characterized, and no targeted therapies are currently applicable.

Pediatric considerations

CEOT in children and adolescents is extremely rare (~7% of cases).[8] Presentation and histology are similar to adult cases, but recurrence has been documented in adolescents, reinforcing the need for long-term follow-up even in young patients.[8]

Multifocal CEOT

Synchronous multifocal CEOT is exceedingly rare; the largest reported case involved 13 independent lesions across all quadrants, each associated with an impacted tooth.[7] No syndromic association has been established.